Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

During the Trading Day
0.705 -0.0289 / -3.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.76 +0.055 / +7.80%
 
Volume: 1.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues68.7M24.6M9.3M8.9M
 
 
 
 
 
Cost of Goods Sold47.1M2.5M0.00--
 
 
 
Depreciation And Amortization2.4M1.1M100.0K100.0K
 
 
 
 
 
 
Operating ExpensesGross Income19.2M21.0M9.2M--
 
 
 
 
General Expenses25.1M29.2M34.2M36.2M
 
 
 
 
 
Research And Development15.1M19.8M26.3M28.3M
 
 
 
 
 
Total Operating Expenses74.6M32.8M34.3M36.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.9M-8.2M-25.0M-27.4M
 
 
 
 
 
Extraordinary Charge-4.2M-17.6M0.000.00
 
 
 
Interest Expense On Debt0.00--300.0K1.8M
 
 
 
Other Expenses-1.4M6.6M-200.0K-100.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.3M-19.2M-25.4M-29.1M
 
 
 
 
 
Income Taxes-300.0K-100.0K0.00-300.0K
 
 
 
 
Net Income-11.0M-19.1M-25.4M-29.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.3M35.4M38.6M38.6M
 
 
 
 
 
Shares To Calculate EPS Diluted31.3M35.4M38.6M38.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.54-$0.66-$0.76
 
 
 
 
 
EPS Diluted-$0.35-$0.54-$0.66-$0.76